Beijing Adjusts UEBMI Account Management, Boosting Outpatient Coverage
The Beijing Municipal Medical Insurance Bureau has adjusted the management of Urban Employee Basic Medical...
Policy / Regulatory
China-U.S. Listing Agreement Clears Path for Chinese Firms to Stay Listed in the U.S.
China and the United States are nearing an agreement that would allow Chinese firms to...
Shandong Releases Off-Label Drug Use Consensus, Expanding Clinical Guidance
The Shandong Pharmaceutical Association (SPA) has released the “Shandong Province Expert Consensus on Off-label Drug...
NMPA Releases 57th Batch of Reference Drugs for Generic Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 57th batch of reference drugs for...
NMPA Reclassifies Omeprazole Tablets from Prescription to OTC Status
The National Medical Products Administration (NMPA) announced that omeprazole enteric-coated tablets have been reclassified from...
NMPA Suspends UCB’s Keppra Over Labeling Issues, Prompting Recall
The National Medical Products Administration (NMPA) has suspended approval for UCB’s Keppra (levetiracetam) concentrated solution...
China’s Health Commission Promotes Medical-Elderly Care Integration
China’s National Health Commission (NHC), National Development and Reform Commission (NDRC), and National Healthcare Security...
China Passes WHO NRA Evaluation for Vaccine Regulatory System
The World Health Organization (WHO) announced that China has successfully passed the evaluation of its...
NHSA Proposes Regulations to Standardize Oral Implant Charges and Reduce Costs
The National Healthcare Security Administration (NHSA) has released a draft proposal titled “Notice on Carrying...
NHC, NDRC Issue Guidelines to Boost China’s Birth Rates with Reproductive Support Measures
The National Health Commission (NHC) and National Development and Reform Commission (NDRC), along with multiple...
CDE Releases Draft Guidelines for RWE-Backed Drug Registration Applications
The Center for Drug Evaluation (CDE) has released a notification regarding the “Real-World Evidence (RWE)-backed...
China Ramps Up Monitoring of Clinically Shortage Drugs Involving 109 Varieties
The Ministry of Industry and Information Technology (MIIT), National Health Commission (NHC), National Healthcare Security...
Taihu Bay Healthcare Conference Launches Wuxi IP Protection Center
The 2022 Taihu Bay Future Healthcare Conference was held in Wuxi City, Jiangsu province, China,...
NHSA Cracks Down on Price Gouging in Basic Medical Insurance Scheme
The National Healthcare Security Administration (NHSA) has announced the results of a special investigation, revealing...
CDE Issues Q&As on COVID-19 Antiviral Drug Evaluation Criteria
The Center for Drug Evaluation (CDE) has published a list of Q&As regarding the non-clinical...
NHC Issues Notification on Medication Safety Management and Rational Drug Use
The National Healthcare Commission (NHC) has released a notification focusing on medication safety management and...
NHC Designates National Mental Illness Medical Centers in Beijing and Shanghai
The National Healthcare Commission (NHC) announced the establishment of national mental illness medical centers, designating...
Shenzhen Unveils Measures to Boost Biomedical and Medical Device Industries
Shenzhen’s municipal Development and Reform Commission has released a series of measures to promote the...
Sun Pharma’s Bicalutamide Supply Suspended in Multiple Chinese Regions
India-based Sun Pharma has suspended the supply of its bicalutamide to Beijing, Tianjin, Jilin, Shanghai,...
CDE Releases 61st Batch of Generic Reference Preparations, 34 New Specs Added
The Center for Drug Evaluation (CDE) has released the 61st batch of chemical generic reference...